Pharmacokinetics of the new hepatitis c virus ns3 protease inhibitor narlaprevir following single-dose use with or without ritonavir in patients with liver cirrhosis

Authors
Isakov V. 1 , Koloda D. 1 , Tikhonova N. 1 , Krasavina E. 1 , Samsonov M. 1 , Kikalishvili T. 1 , Lekishvili K. 1 , Malaya I. 1 , Ryska M. 1 , Tolkacheva V. 1
Journal
Antimicrobial Agents and Chemotherapy
Issue number
12
Language
English
State
Published
Volume
60
Year
2016
Organizations
  • 1 Peoples Friendship University of Russia
Cite
ГОСТ MLA RIS BibTex
Share

Other records